Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-25-000009

Chief Scientific Officer sold 6,500 shares at $4.97 ($32,287)

  • Chief Scientific Officer acquired 6,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-10-20 Exercise or conversion : show line 1 in the form 10b5-1 +6,500 $0.06 $390 6,500 D
2025-10-20 Sale : show line 2 in the form 10b5-1 −6,500 $4.97 $32,287 0 D
Open-market sales · 6,500 sh · avg $4.97 · $32,287

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-20 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −6,500 410,686 D
Loading xslF345X05/wk-form4_1761063888.xml…